Clinical trial
Relationship Between T LYmphocytes Depletion and Clinical Response to RITUXimab in Rheumatoid Arthritis (LYRITUX)
NCT02304354 is registered in ClinicalTrials.gov with University Hospital, Tours as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Relationship Between T LYmphocytes Depletion and Clinical Response to RITUXimab in Rheumatoid Arthritis (LYRITUX)
- Lead sponsor
- University Hospital, Tours
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 9, 2015
- Completion date
- December 18, 2019
- Enrollment
- 70 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
rheumatoid arthritis